Clinical Endocrinology

The tumour vanishes
pp. 663-664(2)
Authors: Todd J.F.; Meeran K.

Growth hormone treatment of short stature due to intrauterine growth retardation
pp. 665-666(2)
Author: Stanhope R.

No advantage of the new combined octreotide-GHRH test over established GH-stimulation tests in the diagnosis of growth hormone deficiency (GHD) in adults
pp. 667-674(08)
Authors: Schütz F.; Wüster C.; Heilmann P.; Ziegler R.; Hadji P.

Body proportions during 6 years of GH treatment in children with short stature born small for gestational age participating in a randomised, double-blind, dose–response trial*
pp. 675-681(7)
Authors: Sas T.C.J.; Gerver W-J.M.; de Bruin R.; Mulder P.G.H.; Cole T.J.; de Waal W.; Hokken-Koelega A.C.S.

Serum levels of free insulin-like growth factor (IGF)-I and IGF-binding protein-1 in prepubertal children with idiopathic short stature
pp. 683-688(6)
Authors: Kamoda T.; Saitoh H.; Hirano T.; Matsui A.

Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort
pp. 689-695(7)
Authors: Leifke E.; Gorenoi V.; Wichers C.; von zur Mühlen A.; von Büren E.; Brabant G.

The testosterone:androstenedione ratio in male undermasculinization
pp. 697-702(6)
Authors: Faisal Ahmed S.; Iqbal A.; Hughes I.A.

Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men
pp. 703-711(9)
Authors: Smith K.W.; Feldman H.A.; McKinlay J.B.

Non-functioning pituitary adenomas: indications for postoperative radiotherapy
pp. 713-717(5)
Authors: Woollons A.C.; Hunn M.K.; Rajapakse Y.R.; Toomath R.; Hamilton D.A.; Conaglen J.V.; Balakrishnan V.

Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration
pp. 719-724(6)
Authors: Jenkins P.J.; Akker S.; Chew S.L.; Besser G.M.; Monson J.P.; Grossman A.B.

Goitrogenesis during pregnancy and neonatal hypothyroxinaemia in a borderline iodine sufficient area
pp. 725-731(7)
Authors: Kung A.W.C.; Lao T.T.; Chau M.T.; Tam S.C.F.; Low L.C.K.

Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study
pp. 733-737(5)
Authors: Kalmijn S.; Mehta K.M.; Pols H.A.P.; Hofman A.; Drexhage H.A.; Breteler M.M.B.

Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies
pp. 739-747(9)
Authors: Suzuki T.; Sasano H.; Takeyama J.; Kaneko C.; Freije W.A.; Carr B.R.; Rainey W.E.

Concurrent secretion of aldosterone and cortisol from an adrenal adenoma — value of MRI in diagnosis
pp. 749-753(05)
Authors: Allan C.A.; Kaltsas G.; Perry L.; Lowe D.G.; Reznek R.; Carmichael D.; Monson J.P.

Complete histological regression of metastatic carcinoid tumour after treatment with octreotide
pp. 755-758(04)
Authors: Imtiaz K.E.; Monteith P.; Khaleeli A.

The low dose ACTH stimulation test is less sensitive than the overnight metyrapone test for the diagnosis of secondary hypoasrenalism
pp. 759-759(3)
Author: Jolobe O.M.P.

Reply
pp. 759-760(3)
Author: Soule S.

A longitudinal study on bone mineral density until adulthood in girls with Turner’s syndrome participating in a growth hormone injection frequency-response trial
pp. 760-761(3)
Authors: Lanes R.; Gunczler P.